WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke ULIBDI wurde als Wortmarke am 21.02.2023 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1739717 |
| Länder | 
|
| Basismarke |
Nr. 97560320,
23. August 2022
|
| Anmeldedatum | 21. Februar 2023 |
| Ablaufdatum | 21. Februar 2033 |
Markeninhaber
3050 Science Park Rd.
San Diego CA 92037
US
San Diego CA 92037
US
Markenvertreter
1840 Century Park East, Suite 1900
Los Angeles CA 90067
US
Waren und Dienstleistungen
05
Pharmaceutical preparations used for the treatment of
gastrointestinal disorders and diseases, colitis, Crohn's
disease, Inflammatory Bowel Disease, systemic sclerosis,
Interstitial Lung Disease, Systemic sclerosis-associated
interstitial lung disease, arthritis, and other diseases of
the immune, digestive, bowel, skin, joint, lung, liver,
kidney, bile duct, or gastrointestinal systems, immune
modulation and management of side effects associated with
renal disorders and cancer; diagnostic preparations for
clinical or medical laboratory use; diagnostic reagents for
clinical or medical laboratory use
42
Medical laboratory services, namely, laboratory testing,
medical diagnostic testing, evaluation, and medical research
services; medical laboratory services, namely, laboratory
testing in the field of disease management and pathology and
of patient diagnosis and patient selection
44
Disease management services namely medical analysis services
for diagnostic and treatment purposes and managing patient
data; medical services, namely, providing medical
information to health care providers, managed care providers
and patients via computer networks; providing health
information in the field of gastrointestinal diseases,
colitis, Crohn's disease, Inflammatory Bowel Disease,
systemic sclerosis, Interstitial Lung Disease, Systemic
sclerosis-associated interstitial lung disease, arthritis,
and other diseases of the immune, digestive, bowel, skin,
joint, lung, liver, kidney, bile duct, or gastrointestinal
systems; providing information relating to medical
diagnostic testing; providing information relating to
treatment recommendation; medical consultation; providing
information about services for the diagnosis, prevention,
and treatment of gastrointestinal disorders and diseases,
colitis, Crohn's disease, Inflammatory Bowel Disease,
systemic sclerosis, Interstitial Lung Disease, Systemic
sclerosis-associated interstitial lung disease, arthritis,
and other diseases of the immune, digestive, bowel, skin,
joint, lung, liver, kidney, bile duct, or gastrointestinal
systems, immune modulation and management of side effects
associated with renal disorders and cancer via a websiter
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 21. Februar 2023 | 2023/26 Gaz | US | Eintragung |
ID: 141739717